Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock

Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial (RCT).

Rapid identification of disease-causing bacteria using Raman spectroscopy

Study in BioRisk explores the use of Raman spectroscopy for rapid identification of Pseudomonas aeruginosa, a bacteria causing serious human diseases, demonstrating its potential as

December 14, 2023

MHRA approves licence change for Pfizer-BioNTech’s vaccine

Share this article The formulation of the Comirnaty vaccine, approved in September 2023, remains unchanged. Credit: Studio Romantic / Shutterstock.com. The UK Medicines and Healthcare

February 12, 2024

Subretinal Drusenoid Deposits Linked to Carotid Artery Stenosis

A presentation during the recent American Society of Retina Specialists (ASRS) annual meeting highlighted a study that demonstrated that patients with a specific symptom of

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.